{"answer":{"query":"enbrel","resolved_as":"name","packages":23,"applications":["BLA103795"],"identity":{"application_numbers":["BLA103795"],"marketing_categories":["BLA"],"labelers":[{"text":"IMMUNEX CORPORATION","untrusted":true}],"dosage_forms":[{"text":"SOLUTION","untrusted":true}],"marketing_start":{"earliest":"2019-06-07","latest":"2020-03-05","packages_with_a_start_date":6}},"price":{"median_negotiated_over_nadac":0.28,"packages_compared":5,"packages_listed":23,"negotiated_price_ends":null,"rows":[{"ndc":"58406001001","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.587064,"ratio":null,"ful_per_unit":null},{"ndc":"58406001004","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":"B","nadac_per_unit":2083.77722,"negotiated_per_unit":583.587064,"ratio":0.28,"ful_per_unit":null},{"ndc":"58406002101","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.621067,"ratio":null,"ful_per_unit":null},{"ndc":"58406002104","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":"B","nadac_per_unit":2080.97109,"negotiated_per_unit":583.621067,"ratio":0.28,"ful_per_unit":null},{"ndc":"58406003201","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.766898,"ratio":null,"ful_per_unit":null},{"ndc":"58406003204","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":"B","nadac_per_unit":2083.62477,"negotiated_per_unit":583.766898,"ratio":0.28,"ful_per_unit":null},{"ndc":"58406004401","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.542345,"ratio":null,"ful_per_unit":null},{"ndc":"58406004404","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":"B","nadac_per_unit":2081.679,"negotiated_per_unit":583.542345,"ratio":0.28,"ful_per_unit":null},{"ndc":"58406004424","name":{"text":"","untrusted":true},"class":"B","nadac_per_unit":2081.679,"negotiated_per_unit":583.542345,"ratio":0.28,"ful_per_unit":null},{"ndc":"58406005501","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":582.442177,"ratio":null,"ful_per_unit":null},{"ndc":"58406005504","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":582.442177,"ratio":null,"ful_per_unit":null},{"ndc":"58406042534","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":288.304001,"ratio":null,"ful_per_unit":null},{"ndc":"58406042541","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":288.304001,"ratio":null,"ful_per_unit":null},{"ndc":"58406043501","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.621067,"ratio":null,"ful_per_unit":null},{"ndc":"58406043504","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.621067,"ratio":null,"ful_per_unit":null},{"ndc":"58406044501","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.766898,"ratio":null,"ful_per_unit":null},{"ndc":"58406044504","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.766898,"ratio":null,"ful_per_unit":null},{"ndc":"58406044601","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.766898,"ratio":null,"ful_per_unit":null},{"ndc":"58406044604","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.766898,"ratio":null,"ful_per_unit":null},{"ndc":"58406045501","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.587064,"ratio":null,"ful_per_unit":null},{"ndc":"58406045504","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.587064,"ratio":null,"ful_per_unit":null},{"ndc":"58406045601","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.542345,"ratio":null,"ful_per_unit":null},{"ndc":"58406045604","name":{"text":"ENBREL (etanercept)","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":583.542345,"ratio":null,"ful_per_unit":null}],"negotiated_scheduled":{"thirty_day":2418.7,"effective":"2027-01-01"}},"label_history":{"events_total":94,"non_cmc_events":92,"counts_by_class":{"LABELING":45,"EFFICACY":20,"UNKNOWN":1,"S":26},"cmc_events":2,"recent_non_cmc_events":[{"application":"BLA103795","submission_no":5610,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2026-10-14","documents":[{"type":"Letter","date":"2026-10-16","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/103795Orig1s5610ltr.pdf","untrusted":true}}],"fact_id":"a75d868e0e4f3ebc1890a230"},{"application":"BLA103795","submission_no":5605,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2026-01-30","documents":[{"type":"Letter","date":"2026-02-03","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/103795Orig1s5605ltr.pdf","untrusted":true}},{"type":"Label","date":"2026-02-06","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/103795s5605lbl.pdf","untrusted":true}}],"fact_id":"2c70d5e9663f84f7dd2fb5ab"},{"application":"BLA103795","submission_no":5604,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-12-10","documents":[{"type":"Letter","date":"2025-12-11","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/103795Orig1s5604ltr.pdf","untrusted":true}}],"fact_id":"edfdd00fc8c511c130fb85c7"},{"application":"BLA103795","submission_no":5603,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-06-18","documents":[{"type":"Label","date":"2025-06-20","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/103795Orig1s5603lbl.pdf","untrusted":true}},{"type":"Letter","date":"2025-06-20","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/103795Orig1s5603ltr.pdf","untrusted":true}}],"fact_id":"20b971e918adc6ed17d98427"},{"application":"BLA103795","submission_no":5600,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2024-09-12","documents":[{"type":"Label","date":"2024-09-16","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103795s5600lbl.pdf","untrusted":true}},{"type":"Letter","date":"2024-09-16","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/103795Orig1s5600ltr.pdf","untrusted":true}}],"fact_id":"ac4ac33a97a6c7dcc00c85a2"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":2,"te_code_counts":{"NOT_PROVIDED":2},"marketing_status_counts":{"Prescription":2},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"BLA103795","product_no":"001","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"ENBREL","untrusted":true},"form":{"text":"VIAL; SUBCUTANEOUS","untrusted":true},"strength":{"text":"25MG/VIAL","untrusted":true}},{"application":"BLA103795","product_no":"002","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"ENBREL","untrusted":true},"form":{"text":"SYRINGE","untrusted":true},"strength":{"text":"50MG/ML","untrusted":true}}]},"supply":{"fda_shortage_status_counts":{},"packages_with_a_termination_date":10,"next_package_termination_dates":[],"packages_with_future_termination_date":0,"termination_meaning":"manufacturer-reported last-lot expiry or withdrawal date of one package; other packages and generics can remain"},"trials":{"attribution":"Source: ClinicalTrials.gov","modification_statement":"OmniRx has summarized and trimmed this ClinicalTrials.gov data.","not_an_offer":"A recruiting trial listing is not an offer of free drug and not medical advice; enrollment is decided by the study team.","ingredients":[{"ingredient":{"text":"ETANERCEPT","untrusted":true},"recruiting_interventional_count":13,"not_yet_recruiting_count":2,"by_phase":{"PHASE3":2,"PHASE2":1,"NA":2,"PHASE1":1,"PHASE2/PHASE3":1,"PHASE4":6},"registry_processing_date":"2026-11-06T10:00:05","modifications":"Counts and phase tallies computed here from the full recruiting result set; trials trimmed to the 25 most recently updated, conditions to 3, countries to 10 distinct; no text edited.","recent_trials":[{"nct_id":"NCT06654882","title":{"text":"Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis","untrusted":true},"phase":["PHASE3"],"sponsor":{"text":"Duke University","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-10-21","start_date":"2026-01-09","link":{"text":"https://clinicaltrials.gov/study/NCT06654882","untrusted":true}},{"nct_id":"NCT07138898","title":{"text":"Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty","untrusted":true},"phase":["PHASE2"],"sponsor":{"text":"NYU Langone Health","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-07-09","start_date":"2025-12-12","link":{"text":"https://clinicaltrials.gov/study/NCT07138898","untrusted":true}},{"nct_id":"NCT07184853","title":{"text":"Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD","untrusted":true},"phase":["NA"],"sponsor":{"text":"First Affiliated Hospital of Zhejiang University","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-07-07","start_date":"2025-09-25","link":{"text":"https://clinicaltrials.gov/study/NCT07184853","untrusted":true}},{"nct_id":"NCT03414502","title":{"text":"Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response","untrusted":true},"phase":["PHASE3"],"sponsor":{"text":"University of Nebraska","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-06-17","start_date":"2007-12-10","link":{"text":"https://clinicaltrials.gov/study/NCT03414502","untrusted":true}},{"nct_id":"NCT06585384","title":{"text":"Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease","untrusted":true},"phase":["PHASE1"],"sponsor":{"text":"Fondation Ophtalmologique Adolphe de Rothschild","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-05-12","start_date":"2025-04-15","link":{"text":"https://clinicaltrials.gov/study/NCT06585384","untrusted":true}}],"fact_id":"024989c700d51e005ae9f8da"}]},"assistance_and_offers":{"programs_listing_this_drug":[{"name":{"text":"Amgen Safety Net Foundation","untrusted":true},"type":"manufacturer","url":"https://www.amgensafetynetfoundation.com/","status":null,"needs_status_check":false,"has_offer":false},{"name":{"text":"TAF Cares (The Assistance Fund)","untrusted":true},"type":"nonprofit","url":"https://tafcares.org/","status":null,"needs_status_check":false,"has_offer":false}],"manufacturer_offers":[],"note":"A program that lists a drug has not decided anything about any person: each program decides who qualifies, and a status other than open means it may not take new patients. Offers change and expire; read each offer's source and stated end date. A price figure is what the page states, not a quote."},"spending":{"reported_under":{"generic":{"text":"Etanercept","untrusted":true},"brand":{"text":"Enbrel","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":583367035.1,"claims":90789,"beneficiaries":12573,"average_spending_per_claim_usd":6425.5255053,"fact_id":"07ad4f0fa833c455455c39c8"},{"year":2021,"gross_spending_usd":590851426.13,"claims":88581,"beneficiaries":12049,"average_spending_per_claim_usd":6670.1823882,"fact_id":"f91dc7142f4de3b93082bfbf"},{"year":2022,"gross_spending_usd":612015041.88,"claims":85310,"beneficiaries":11311,"average_spending_per_claim_usd":7174.0129162,"fact_id":"465f9f8ebe3c54c5f6a66c04"},{"year":2023,"gross_spending_usd":627419986.53,"claims":81987,"beneficiaries":10678,"average_spending_per_claim_usd":7652.6764796,"fact_id":"40f52924e2e620f9de8b2ff6"},{"year":2024,"gross_spending_usd":632791430.87,"claims":80845,"beneficiaries":10542,"average_spending_per_claim_usd":7827.2178968,"fact_id":"a33fd33dcd172cbfbfa9f0c2"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"biologic_status":{"products":[{"application":"BLA103795","status":"Reference","name":{"text":"Enbrel; Enbrel Mini","untrusted":true},"proper_name":{"text":"etanercept","untrusted":true},"license_status":"Licensed","approval_date":"1998-11-02","reference_product":null,"interchangeable_date":null,"biosimilars_listed":1,"interchangeables_listed":1,"biosimilars":[{"name":{"text":"Erelzi; Erelzi Sensoready","untrusted":true},"proper_name":{"text":"etanercept-szzs","untrusted":true},"bla_number":"761042","approval_date":"2016-08-30","interchangeable_date":null}],"interchangeables":[{"name":{"text":"Eticovo","untrusted":true},"proper_name":{"text":"etanercept-ykro","untrusted":true},"bla_number":"761066","approval_date":"2019-04-25","interchangeable_date":"2024-06-25"}],"purple_book_version":"purplebook-2026-10","read_on":"2026-11-07T07:33:31.186Z","fact_id":"222b7784954acb186ea62e0e"}],"reading":"what the FDA Purple Book lists on its read date, a record and not a forecast of launch or substitution"},"rems":{"programs":[{"application":"BLA103795","program":{"text":"Enbrel","untrusted":true},"rems_id":"189","in_force":false,"released":true,"moved_to_shared_system":false,"has_etasu":false,"program_date":"2008-06-23","last_modified":"2011-08-10","source_page":"https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=IndvRemsDetails.page&REMS=189","other_programs":0,"read_on":"2026-11-07T20:05:28.959Z","fact_id":"edd8725821466639b21cbb9a"}],"reading":"what the FDA REMS@FDA files tie to the application on the read date; it does not say which prescribers or pharmacies take part or whether a patient needs the program"},"orphan_designation":{"ingredients":[{"ingredient":{"text":"Etanercept; etanercept","untrusted":true},"designation_count":2,"approved_count":1,"recent":[{"designated":"1999-04-06","use":{"text":"Treatment of Wegener's granulomatosis.","untrusted":true},"status":"Designated/Designation Withdrawn or Revoked","sponsor":{"text":"Immunex Corporation","untrusted":true},"approved":false},{"designated":"1998-10-27","use":{"text":"Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying ant","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"Immunex Corporation","untrusted":true},"approved":true}],"read_on":"2026-11-07T12:00:00.000Z","fact_id":"ef73b5f267e211ee0b884cc8"}],"reading":"a designation is not an approval and not a statement that the drug treats the condition; status is the FDA database's own"},"medicaid_state_utilization":{"year":2025,"states_with_data":10,"all_states_medicaid_reimbursed_usd":5157781.1,"all_states_medicaid_paid_prescriptions":821,"top_states":[{"state":"NC","medicaid_paid_prescriptions":142,"medicaid_reimbursed_usd":878373.21,"total_reimbursed_usd":881140.68,"packages":1,"covers":"all_record_types","fact_id":"d079288b99a128446ca2a842"},{"state":"UT","medicaid_paid_prescriptions":83,"medicaid_reimbursed_usd":720783.98,"total_reimbursed_usd":732898.01,"packages":1,"covers":"fee_for_service_only","fact_id":"fd6620caee40e8d3d6525046"},{"state":"OH","medicaid_paid_prescriptions":118,"medicaid_reimbursed_usd":696817.19,"total_reimbursed_usd":715674.96,"packages":1,"covers":"fee_for_service_only","fact_id":"d59f7f675fdfe44d26fe27ec"},{"state":"NV","medicaid_paid_prescriptions":76,"medicaid_reimbursed_usd":610523.19,"total_reimbursed_usd":610523.19,"packages":1,"covers":"fee_for_service_only","fact_id":"65b0d7b86419accdbcb886c9"},{"state":"AZ","medicaid_paid_prescriptions":96,"medicaid_reimbursed_usd":517724.98,"total_reimbursed_usd":517724.98,"packages":1,"covers":"all_record_types","fact_id":"8282dca6ca3657d47cbc08b3"},{"state":"OR","medicaid_paid_prescriptions":61,"medicaid_reimbursed_usd":460407.7,"total_reimbursed_usd":460407.7,"packages":1,"covers":"fee_for_service_only","fact_id":"585f5edb7762ab59c4cf2d42"},{"state":"GA","medicaid_paid_prescriptions":56,"medicaid_reimbursed_usd":361508.16,"total_reimbursed_usd":361508.16,"packages":1,"covers":"fee_for_service_only","fact_id":"fb3dc9704d2969c1581f3441"},{"state":"PR","medicaid_paid_prescriptions":73,"medicaid_reimbursed_usd":349698.43,"total_reimbursed_usd":370898.32,"packages":1,"covers":"all_record_types","fact_id":"d18bdc6ced2815cdbef01543"},{"state":"MO","medicaid_paid_prescriptions":61,"medicaid_reimbursed_usd":333376.87,"total_reimbursed_usd":333376.87,"packages":1,"covers":"all_record_types","fact_id":"05ebdd287dc2036f9b580ca6"},{"state":"TN","medicaid_paid_prescriptions":55,"medicaid_reimbursed_usd":228567.39,"total_reimbursed_usd":228660.39,"packages":1,"covers":"all_record_types","fact_id":"64ac920923bfa2d9d7d0d3de"}],"unlabelled_state_code_xx":null,"built_from_facts":10,"facts_fee_for_service_only":5,"older_year_facts_not_used":155,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"0eb008fab770fdaa6a4aa94a","field":"ndc.listing","entity":"ndc:58406001004"},{"fact_id":"eec4701cba60e8d2e49bad8e","field":"ndc.listing","entity":"ndc:58406002104"},{"fact_id":"ef8304b7dab7cadceb3f2dd8","field":"ndc.listing","entity":"ndc:58406003204"},{"fact_id":"7e80c768fb2b568b5e4b663b","field":"ndc.nadac_price","entity":"ndc:58406001004"},{"fact_id":"a8b9d2a37374948a28e0f485","field":"ndc.mfp","entity":"ndc:58406001001"},{"fact_id":"a2f8907512384367e04b29be","field":"ndc.mfp","entity":"ndc:58406001004"},{"fact_id":"85bc1a184bed509df28120d5","field":"ndc.mfp","entity":"ndc:58406002101"},{"fact_id":"a75d868e0e4f3ebc1890a230","field":"drug.label_event","entity":"application:BLA103795"},{"fact_id":"2c70d5e9663f84f7dd2fb5ab","field":"drug.label_event","entity":"application:BLA103795"},{"fact_id":"edfdd00fc8c511c130fb85c7","field":"drug.label_event","entity":"application:BLA103795"},{"fact_id":"20b971e918adc6ed17d98427","field":"drug.label_event","entity":"application:BLA103795"},{"fact_id":"ac4ac33a97a6c7dcc00c85a2","field":"drug.label_event","entity":"application:BLA103795"},{"fact_id":"ffb1bbb70d1fbd2eb2e7ff44","field":"drug.marketing_status","entity":"application:BLA103795"},{"fact_id":"296b1433e69a6e074daeb954","field":"drug.marketing_status","entity":"application:BLA103795"},{"fact_id":"024989c700d51e005ae9f8da","field":"drug.trial_access","entity":"drug:etanercept"},{"fact_id":"07ad4f0fa833c455455c39c8","field":"drug.partd_spending","entity":"drug:etanercept|enbrel"},{"fact_id":"f91dc7142f4de3b93082bfbf","field":"drug.partd_spending","entity":"drug:etanercept|enbrel"},{"fact_id":"465f9f8ebe3c54c5f6a66c04","field":"drug.partd_spending","entity":"drug:etanercept|enbrel"},{"fact_id":"40f52924e2e620f9de8b2ff6","field":"drug.partd_spending","entity":"drug:etanercept|enbrel"},{"fact_id":"a33fd33dcd172cbfbfa9f0c2","field":"drug.partd_spending","entity":"drug:etanercept|enbrel"},{"fact_id":"222b7784954acb186ea62e0e","field":"drug.biologic_status","entity":"application:BLA103795"},{"fact_id":"32740fa81337f64246beb5d7","field":"drug.biologic_status","entity":"application:BLA761042"},{"fact_id":"fa83a62f20835b3a3b5b3f5c","field":"drug.biologic_status","entity":"application:BLA761066"},{"fact_id":"edd8725821466639b21cbb9a","field":"drug.rems","entity":"application:BLA103795"},{"fact_id":"ef73b5f267e211ee0b884cc8","field":"drug.orphan_designation","entity":"drug:etanercept"},{"fact_id":"d079288b99a128446ca2a842","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406005504:NC"},{"fact_id":"fd6620caee40e8d3d6525046","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406002104:UT"},{"fact_id":"d59f7f675fdfe44d26fe27ec","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406005504:OH"},{"fact_id":"65b0d7b86419accdbcb886c9","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406002104:NV"},{"fact_id":"8282dca6ca3657d47cbc08b3","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406005504:AZ"},{"fact_id":"585f5edb7762ab59c4cf2d42","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406004404:OR"},{"fact_id":"fb3dc9704d2969c1581f3441","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406005504:GA"},{"fact_id":"d18bdc6ced2815cdbef01543","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406001004:PR"},{"fact_id":"05ebdd287dc2036f9b580ca6","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406005504:MO"},{"fact_id":"64ac920923bfa2d9d7d0d3de","field":"ndc.medicaid_state_utilization","entity":"ndc_state:58406001004:TN"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["AMBER","GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"generic_entry:BLA103795","reason":"no generic-entry fact for this application: no patent or exclusivity is listed for it in the Orange Book edition read, so no date is stated"},{"code":"NO_DATA","field":"generic_entry","reason":"no application of this drug has a generic-entry fact; no date is stated"},{"code":"NO_DATA","field":"recalls","reason":"no FDA enforcement report naming a package of these applications is recorded"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"NO_DATA","field":"payment_limit","reason":"no HCPCS code whose NDC crosswalk names a package of these applications has a Part B payment limit in the edition"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}